These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 12473583)
1. Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter. Sträter J; Hinz U; Walczak H; Mechtersheimer G; Koretz K; Herfarth C; Möller P; Lehnert T Clin Cancer Res; 2002 Dec; 8(12):3734-40. PubMed ID: 12473583 [TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of APAF-1, caspase-8 and caspase-9 in stage II/III colon carcinoma: caspase-8 and caspase-9 is associated with poor prognosis. Sträter J; Herter I; Merkel G; Hinz U; Weitz J; Möller P Int J Cancer; 2010 Aug; 127(4):873-80. PubMed ID: 20013803 [TBL] [Abstract][Full Text] [Related]
3. Tissue distribution of the death ligand TRAIL and its receptors. Spierings DC; de Vries EG; Vellenga E; van den Heuvel FA; Koornstra JJ; Wesseling J; Hollema H; de Jong S J Histochem Cytochem; 2004 Jun; 52(6):821-31. PubMed ID: 15150291 [TBL] [Abstract][Full Text] [Related]
4. The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. Meng RD; McDonald ER; Sheikh MS; Fornace AJ; El-Deiry WS Mol Ther; 2000 Feb; 1(2):130-44. PubMed ID: 10933923 [TBL] [Abstract][Full Text] [Related]
5. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Zhang XD; Franco A; Myers K; Gray C; Nguyen T; Hersey P Cancer Res; 1999 Jun; 59(11):2747-53. PubMed ID: 10364001 [TBL] [Abstract][Full Text] [Related]
6. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2. Chamuleau ME; Ossenkoppele GJ; van Rhenen A; van Dreunen L; Jirka SM; Zevenbergen A; Schuurhuis GJ; van de Loosdrecht AA Leuk Res; 2011 Jun; 35(6):741-9. PubMed ID: 21281967 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of TRAIL-R1 and TRAIL-R3 expression in metastatic colorectal carcinomas. Granci V; Bibeau F; Kramar A; Boissière-Michot F; Thézénas S; Thirion A; Gongora C; Martineau P; Del Rio M; Ychou M Eur J Cancer; 2008 Oct; 44(15):2312-8. PubMed ID: 18755584 [TBL] [Abstract][Full Text] [Related]
8. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells. Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286 [TBL] [Abstract][Full Text] [Related]
10. Expression of tumor necrosis factor- alpha -related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains. Neu B; Rad R; Reindl W; Neuhofer M; Gerhard M; Schepp W; Prinz C J Infect Dis; 2005 Feb; 191(4):571-8. PubMed ID: 15655781 [TBL] [Abstract][Full Text] [Related]
11. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils. Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904 [TBL] [Abstract][Full Text] [Related]
13. In chronic pancreatitis, widespread emergence of TRAIL receptors in epithelia coincides with neoexpression of TRAIL by pancreatic stellate cells of early fibrotic areas. Hasel C; Dürr S; Rau B; Sträter J; Schmid RM; Walczak H; Bachem MG; Möller P Lab Invest; 2003 Jun; 83(6):825-36. PubMed ID: 12808117 [TBL] [Abstract][Full Text] [Related]
14. Expression of TRAIL and its receptors in human brain tumors. Frank S; Köhler U; Schackert G; Schackert HK Biochem Biophys Res Commun; 1999 Apr; 257(2):454-9. PubMed ID: 10198234 [TBL] [Abstract][Full Text] [Related]
15. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme. Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. Lonergan M; Aponso D; Marvin KW; Helliwell RJ; Sato TA; Mitchell MD; Chaiwaropongsa T; Romero R; Keelan JA J Clin Endocrinol Metab; 2003 Aug; 88(8):3835-44. PubMed ID: 12915677 [TBL] [Abstract][Full Text] [Related]
17. Restricted expression of tumor necrosis factor-related apoptosis-inducing ligand receptor 4 in human peripheral blood lymphocytes. Hasegawa H; Yamada Y; Harasawa H; Tsuji T; Murata K; Sugahara K; Tsuruda K; Masuda M; Takasu N; Kamihira S Cell Immunol; 2004; 231(1-2):1-7. PubMed ID: 15919363 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients. van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118 [TBL] [Abstract][Full Text] [Related]